Therapy and clinical trials: HDL-cholesterol and niacin therapy--past, present, and future

Curr Opin Lipidol. 2010 Apr;21(2):165-6. doi: 10.1097/MOL.0b013e32833768fd.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Cholesterol, HDL / blood*
  • Cholesterol, LDL / blood
  • Clinical Trials as Topic / trends
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hyperlipidemias / blood
  • Hyperlipidemias / drug therapy
  • Niacin / pharmacology
  • Niacin / therapeutic use*

Substances

  • Cholesterol, HDL
  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Niacin